Annovis Bio, Inc. 10-K filing
Filed 2026-03-13 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001104659-26-027751
- Form type
- 10-K
- CIK
- 0001477845
- Primary document
- https://www.sec.gov/Archives/edgar/data/1477845/000110465926027751/anvs-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Annovis Bio, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-29.7M | - | - |
| Net Income | $-28.9M | - | - |
| Eps Basic | -1.4 | - | - |
| Eps Diluted | -1.4 | - | - |
| Cash And Equivalents | $19.5M | - | - |
| Total Assets | $21.1M | - | - |
| Total Liabilities | $4.2M | - | - |
| Shareholders Equity | $16.9M | - | - |
| Operating Cash Flow | $-25.6M | - | - |